â– LECTURE OVERVIEW: Rigor Mortis is a major postmortem change characterized by the physical stiffening of muscles, skeletal tissues, and joints following somatic death.
â– THE ACTION AND KINETIC STEPS:
1. Loss of Mitochondrial Function: At death, systemic circulation halts, depleting oxygen and shutting down oxidative phosphorylation.
2. ATP Depletion: Cytoplasmic ATP is depleted to absolute zero.
3. Sarcoplasmic Retention: The sarcoplasmic calcium-ATPase pump stops running, allowing Ca2+ to leak from the extracellular fluid and sarcoplasmic reticulum into the myofibrillar cytoplasm.
4. Persistent Cross-bridges: Calcium binds to troponin, exposing actin-myosin binding sites. Myosin heads bind to actin to perform the contraction stroke. However, because ATP is completely absent, myosin cannot detach from actin, locking all muscles in a state of rigid contraction.
5. Passive Resolution: Stiffening persists until autolytic lysosomal enzymes start digesting the actin-myosin protein filaments (secondary flaccidity), ending the rigor.
â– PROFESSOR'S ADVANCED PATHOPHYSIOLOGY:
The cellular cascade undergoes active remodeling in response to sustained stressors. Intracellular signalling involves key phosphorylation tracks and secondary lipid messengers, culminating in altered gene transcription and structural adaptations in target tissues.
â– SECONDARY PREVENTION METRICS:
Implementing long-term dietary adaptations, physical therapy, and compliance aids reduces the rate of recurring acute crises by more than half.
[HY-BOARD-1221]
🌟 Dynamic Clinical Key:
In temperate zones, rigor mortis follows a classic postmortem timeline: begins in the involuntary muscles, eyelids, and jaw at 2-4 hours, becomes fully established in all skeletal muscles at 12 hours, is maintained for 12 hours, and passes off in the same descending order over the subsequent 12 hours. Assess patient clearance profiles (creatinine clearance and LFTs) before starting multi-drug regimens to avoid severe toxic accumulation. Patient education regarding warning signs and therapy adherence is the cornerstone of secondary prevention.